Related Experiment Video
Updated: May 29, 2026

Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells
Published on: March 16, 2017
Nanocarriers for nitric oxide delivery
Juliana Saraiva1, Samantha S Marotta-Oliveira, Simone Aparecida Cicillini
1Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, 14010-903 Ribeirão Preto, SP, Brazil.
Abstract:
Nitric oxide (NO) is a promising pharmaceutical agent that has vasodilative, antibacterial, and tumoricidal effects. To study the complex and wide-ranging roles of NO and to facilitate its therapeutic use, a great number of synthetic compounds (e.g., nitrosothiols, nitrosohydroxyamines, N-diazeniumdiolates, and nitrosyl metal complexes) have been developed to chemically stabilize and release NO in a controlled manner. Although NO is currently being exploited in many biomedical applications, its use is limited by several factors, including a short half-life, instability during storage, and potential toxicity. Additionally, efficient methods of both localized and systemic in vivo delivery and dose control are needed. One strategy for addressing these limitations and thus increasing the utility of NO donors is based on nanotechnology.
Related Concept Videos
Nitric Oxide Signaling Pathway
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Drug Delivery: Enteral Route
Drugs in...
Antihypertensive Drugs: Vasodilators
Modified-Release Drug Delivery Systems: Site-Targeted

